Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed H Sayegh

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
Kidney International. Supplement|December 1, 2010
Chronic renal allograft dysfunction (CAD): new frontiers. IntroductionMohamed H Sayegh
Nature Clinical Practice. Nephrology|February 26, 2009
Looking into the crystal ball: kidney transplantation in 2025Mohamed H Sayegh
Frontiers in Transplantation|June 26, 2025
Charles Bernard (Bernie) Carpenter, a giant of a mentorMohamed H Sayegh
Journal of the American Society of Nephrology : JASN|December 31, 2005
Measuring T cell alloreactivity to predict kidney transplant outcomes: are we there yet?John Iacomini, Mohamed H Sayegh
F1000 Biology Reports|October 16, 2010
B cell-targeted therapies in autoimmunity: rationale and progressPaolo Fiorina, Mohamed H Sayegh
Nature Clinical Practice. Nephrology|August 26, 2006
Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?Mohamed H Sayegh, Anil Chandraker
Transplant International : Official Journal of the European Society for Organ Transplantation|December 14, 2007
Harnessing negative T-cell costimulatory pathways to promote engraftmentJoyce Popoola, Mohamed H Sayegh
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Maternal acceptance of the fetus: true human toleranceIndira Guleria, Mohamed H Sayegh
Lancet (London, England)|May 22, 2007
Clinical update: immunosuppression minimisationMohamed H Sayegh, Giuseppe Remuzzi
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 13, 2009
Clinical transplantation tolerance: a myth no more, butJamil Azzi, Mohamed H Sayegh
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
Kidney International. Supplement|December 1, 2010
Chronic renal allograft dysfunction (CAD): new frontiers. IntroductionMohamed H Sayegh
Nature Clinical Practice. Nephrology|February 26, 2009
Looking into the crystal ball: kidney transplantation in 2025Mohamed H Sayegh
Frontiers in Transplantation|June 26, 2025
Charles Bernard (Bernie) Carpenter, a giant of a mentorMohamed H Sayegh
Journal of the American Society of Nephrology : JASN|December 31, 2005
Measuring T cell alloreactivity to predict kidney transplant outcomes: are we there yet?John Iacomini, Mohamed H Sayegh
F1000 Biology Reports|October 16, 2010
B cell-targeted therapies in autoimmunity: rationale and progressPaolo Fiorina, Mohamed H Sayegh
Nature Clinical Practice. Nephrology|August 26, 2006
Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?Mohamed H Sayegh, Anil Chandraker
Transplant International : Official Journal of the European Society for Organ Transplantation|December 14, 2007
Harnessing negative T-cell costimulatory pathways to promote engraftmentJoyce Popoola, Mohamed H Sayegh
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Maternal acceptance of the fetus: true human toleranceIndira Guleria, Mohamed H Sayegh
Lancet (London, England)|May 22, 2007
Clinical update: immunosuppression minimisationMohamed H Sayegh, Giuseppe Remuzzi
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 13, 2009
Clinical transplantation tolerance: a myth no more, butJamil Azzi, Mohamed H Sayegh
Pageof 20